Exploring the Future of Brain-Computer Interfaces with Paradromics Inc.

Welcome to this week's Fruitionary Spotlight Snippets! Today we're highlighting Paradromics Inc., a groundbreaking company creating brain-computer interfaces (BCIs) out of Austin, Texas:

Cortical Module

Because of the difficulty of receiving signals from individual neurons, brain implants have long been seen as a concept to be developed in the future. Today with Matt Angle, CEO leading the way, they are on a mission to make brain implants, or BCI’s, a reality with the introduction of their "Connexus Direct Data Interface" (DDI) technology. 

Originally designed for medical applications, this system holds promise not only for restoring communication in severely paralyzed individuals but also for treating various neurological conditions, with potential for broader use in human-computer interaction.

The Connexus DDI system consists of up to four modules that can be installed in different brain regions, totaling 1,684 connected electrodes allowing the decoding of neuron data and allows the user to to interact with external devices, revolutionizing treatment ranging from motor dysfunction to mood disorders

Paradromics Inc. has made significant strides since its inception. In 2017, they received $18 million in funding from DARPA to develop brain-modem interfaces. Recently, they were accepted into the FDA's Total Product Life Cycle Advisory Program. Paradromics Inc. is also on track to begin human clinical trials in 2025, with commercial approval targeted for 2029.

To learn more about Paradromics Inc. BCI technology, visit www.Paradromics.com. If you’re an innovator in biotech looking to share your story, connect with us at www.Fruitionary.com to be featured in an upcoming spotlight!